We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-1.89%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$158M
AUM Growth
-$435M
Cap. Flow
-$425M
Cap. Flow %
-268.84%
Top 10 Hldgs %
51.56%
Holding
73
New
22
Increased
6
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$3.42M
2
MASI
Masimo
MASI
+$3.29M
3
ICUI icon
ICU Medical
ICUI
+$3.09M
4
BRKR icon
Bruker
BRKR
+$2.45M
5
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$1.81M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$33.3M
2
LYRA
LYRA THERAPEUTICS INC
LYRA
+$8.79M
3
DXCM icon
DexCom
DXCM
+$4.16M
4
VKTX icon
Viking Therapeutics
VKTX
+$3.27M
5
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$2.86M

Sector Composition

Rank Sector Weight
1 Healthcare 48.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
51
CALL
Bausch Health
BHC
$2.33B
– –
-400,000
Closed -$4.24M
DXCM icon
52
DexCom
DXCM
$33.8B
– –
-30,000
Closed -$4.16M
EW icon
53
Edwards Lifesciences
EW
$54B
– –
-15,408
Closed -$1.47M
EXAS
54
CALL
DELISTED
Exact Sciences
EXAS
– –
-495,100
Closed -$34.2M
EXAS
55
DELISTED
Exact Sciences
EXAS
– –
-481,910
Closed -$33.3M
GH icon
56
Guardant Health
GH
$22.2B
– –
-100,000
Closed -$2.33M
HUM icon
57
CALL
Humana
HUM
$44.8B
– –
-175,000
Closed -$60.7M
ILCV icon
58
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
– –
-659,000
Closed -$38.6M
INSP icon
59
CALL
Inspire Medical Systems
INSP
$1.71B
– –
-15,000
Closed -$3.22M
INSP icon
60
Inspire Medical Systems
INSP
$1.71B
– –
-15,000
Closed -$2.84M
ISRG icon
61
CALL
Intuitive Surgical
ISRG
$142B
– –
-6,000
Closed -$2.39M
LYRA
62
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
-28,265
Closed -$8.79M
MYGN icon
63
Myriad Genetics
MYGN
$308M
– –
-44,725
Closed -$954K
OEF icon
64
PUT
iShares S&P 100 ETF
OEF
$20.4B
– –
-705,000
Closed -$148M
RCEL icon
65
Avita Medical
RCEL
$254M
– –
-35,000
Closed -$561K
RCKTW icon
66
Rocket Pharmaceuticals Warrant
RCKTW
$278K
– –
-42,960
Closed -$12.9K
RGEN icon
67
Repligen
RGEN
$9.3B
– –
-11,225
Closed -$2.06M
TMCI icon
68
Treace Medical Concepts
TMCI
$308M
– –
-89,897
Closed -$1.17M
TXG icon
69
10x Genomics
TXG
$7.62B
– –
-38,005
Closed -$1.43M
VKTX icon
70
Viking Therapeutics
VKTX
$3.94B
– –
-39,868
Closed -$3.27M
XNTK icon
71
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.22B
– –
-340,000
Closed -$32.3M
SWAV
72
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
– –
-8,771
Closed -$2.86M
DENT
73
CALL
DELISTED
AdvisorShares Dent Tactical ETF
DENT
– –
-950,000
Closed -$9.51M
1 2
3

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2024 Portfolio in Review

As of Q2 2024, Pura Vida Investments held 73 positions worth $158M, down 73% from $593M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments withdrew a net $425M in Q2 2024, closing 24 positions and reducing 19 holdings. Its most notable exit was Exact Sciences, an estimated $33.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 24% a quarter earlier.

Against the trend, Pura Vida Investments opened a new position in Castle Biosciences worth $3.34M.

  • Pura Vida Investments's largest Q2 2024 buy was Castle Biosciences: 153,386 shares worth $3.34M.
  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q2 2024, an estimated $1.81M increase.
  • Pura Vida Investments's biggest Q2 2024 reduction was Elanco Animal Health, cutting an estimated $2.18M.
  • Pura Vida Investments fully exited Exact Sciences in Q2 2024, selling an estimated $33.3M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $158M portfolio in Q2 2024.
  • Pura Vida Investments opened 22 new positions and closed 24 in Q2 2024.
  • Pura Vida Investments's portfolio value fell 73% quarter-over-quarter to $158M.

Based on Pura Vida Investments's 13F filing for Q2 2024, filed 14 Aug 2024.